Disease on EC 2.9.1.1 - L-seryl-tRNASec selenium transferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Hepatitis
Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.
Autoantibodies and antigens in liver diseases--updated.
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis.
Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
[A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis]
[Immunology of liver diseases]
Hepatitis A
False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
Hepatitis, Autoimmune
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis.
Autoantibodies as prognostic markers in autoimmune liver disease.
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis.
Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.
Discrimination of autoimmune hepatitis: autoantibody typing and beyond.
False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Histologic features in autoimmune hepatitis.
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis.
Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis.
Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.
Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children.
Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis.
[A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis]
[Autoimmune hepatitis]
[The clinical laboratory in the diagnosis of autoimmune liver diseases]
Hepatitis, Chronic
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Histologic features in autoimmune hepatitis.
[Immunology of liver diseases]
Liver Cirrhosis, Biliary
Autoantibodies as prognostic markers in autoimmune liver disease.
Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Liver Diseases
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
Diagnostic criteria of autoimmune hepatitis.
Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Liver Failure
Autoantibodies as prognostic markers in autoimmune liver disease.
Neoplasms
Folliculotropic Mycosis Fungoides Associated with Autoimmune Hepatitis.
Nervous System Diseases
Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system.
Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase.
Neurodegenerative Diseases
Post-transcriptional control of selenoprotein biosynthesis.